टाइप 1 मधुमेह का उपचार: शारीरिक इंसुलिन प्रतिस्थापन

References

DOI: 10.2337/dci21-0043

1. Most people with type 1 diabetes should use regimens that mimic physiology as closely as possible, irrespective of the presentation.
2. This is best achieved with either MDI of subcutaneous basal insulin analogs and mealtime rapid-acting or ultra-rapid-acting insulin analogs, or with continuous subcutaneous insulin infusion of a rapid-acting insulin analog via a pump, delivered as continuous basal insulin combined with manual mealtime boluses.
3. Insulin analogs are, therefore, considered the insulins of choice.
4. Preferably MDI but other regimens, including pump or hybrid closed-loop technology, can be started based on individual circumstances.
5. An HbA1c goal for most adults of <53 mmol/mol (<7.0%) without significant hypoglycemia is appropriate.
6. A preprandial capillary plasma glucose target of 4.4–7.2 mmol/L (80–130 mg/dL) is appropriate for many people.
7. A peak postprandial capillary plasma glucose of <10.0 mmol/L (<180 mg/dL) is appropriate for most people with diabetes.
8. For most adults with type 1 diabetes, a target TIR should be above 70%, with TBR less than 4% and less than 1% for clinically significant hypoglycemia.